Literature DB >> 23233076

The risk of death due to cardiorespiratory causes increases with time after right pneumonectomy: a propensity score-matched analysis.

María Rodríguez1, María Teresa Gómez, Marcelo F Jiménez, José Luis Aranda, Nuria Novoa, Gonzalo Varela.   

Abstract

OBJECTIVES: The study aimed to compare in-hospital, 30-day and non-cancer-related 6-month death rates in a series of right and left pneumonectomy cases matched according to functional parameters.
METHODS: A retrospective study was conducted on a series of 263 non-small cell lung cancer patients who underwent pneumonectomy. Left and right pneumonectomy cases were matched according to propensity scores using the following variables: age, coronary artery disease, any other cardiac comorbidity and predicted postoperative forced expiratory volume in the 1st second (ppoFEV1). After matching, 89 pairs of cases were selected. In-hospital, 30-day and 6-month crude and risk-adjusted death rates not related to cancer relapse or distant metastases were calculated for right and left pneumonectomy and compared on 2-by-2 tables using odds ratios. Death hazards were estimated by Cox regression, introducing the following independent variables in the model: age, cardiac comorbidity, ppoFEV1 and occurrence of any postoperative cardiorespiratory complication or bronchial fistula.
RESULTS: Non-cancer-related in-hospital, 30-day and 6-month death rates were, respectively, 8.4 (3.4 in left and 13.5 in right cases; P = 0.015), 11.8 (7.8 in left and 15.7 in right cases; P = 0.10) and 18.5% (12.4 in left and 24.7 in right cases; P = 0.033). On Cox regression, age, right pneumonectomy and the occurrence of postoperative cardiorespiratory complications (but not bronchial fistula) were related to the risk of death at 6 months.
CONCLUSIONS: The risk of death after pneumonectomy increases with time and strongly depends on the side of the operation (it is higher after right pneumonectomy) and on the occurrence of any postoperative cardiorespiratory complication. Neither hospital nor 30-day mortality should be reported as a valid outcome after pneumonectomy since they do not represent the real risk of the operation.

Entities:  

Keywords:  30-day mortality; 6-month mortality; 90-day mortality; In-hospital mortality; Pneumonectomy; Postoperative morbidity

Mesh:

Year:  2012        PMID: 23233076     DOI: 10.1093/ejcts/ezs620

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Editorial comment on: "Major morbidity after video-assisted thoracic surgery lung resections: a comparison between the European Society of Thoracic Surgeons definition and the Thoracic Morbidity and Mortality system" by Sandri A, et al.

Authors:  Pierre-Emmanuel Falcoz
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Comparison of short and long-term results between sleeve resection and pneumonectomy in lung cancer patients over 70 years old: 10 years experience from a single institution in China.

Authors:  Xufeng Pan; Jicheng Tantai; Ling Lin; Kejian Cao; Heng Zhao
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

Review 3.  [Consequences of pneumonectomy in the early and late phases].

Authors:  R A Hatz; L V Klotz
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

4.  Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.

Authors:  Shenhai Wei; Jintao Tian; Xiaoping Song; Bingqun Wu; Limin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-04       Impact factor: 4.553

5.  Effects of Moisture Content and Loading Profile on Changing Properties of Bone Micro-Biomechanical Characteristics.

Authors:  Bowen Wang; Ruisong Chen; Fengrong Chen; Jingjing Dong; Zixiang Wu; Hu Wang; Zhao Yang; Faqi Wang; Jian Wang; Xiaofan Yang; Yafei Feng; Zheyuan Huang; Wei Lei; Haoyuan Liu
Journal:  Med Sci Monit       Date:  2018-04-15

6.  Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis.

Authors:  Bo Jia; Qiwen Zheng; Xinmeng Qi; Jun Zhao; Meina Wu; Tongtong An; Yuyan Wang; Minglei Zhuo; Jianjie Li; Xinghui Zhao; Xue Yang; Jia Zhong; Hanxiao Chen; Zhi Dong; Youwu Shi; Feng Du; Jingjing Wang; Yujia Chi; Xiaoyu Zhai; Ziping Wang
Journal:  Thorac Cancer       Date:  2019-01-09       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.